ilmscore | Prediction Details
"Now even if I were to talk about the q2 numbers, q2 fy2 has increased by 11 in comparison with q2 fy2."
By CA Rachana Phadke Ranade | January 22, 2025 | Pending
From video
Mankind Pharma: Fundamental Analysis | Stocks in Focus - Part 3 | CA Rachana Ranade 00:08:25 - 00:08:31
Interpreted Prediction
Mankind Pharma's Q2 FY25 revenue increased by 11% compared to Q2 FY24.

Prediction Details

Ticker
MANKIND

Comments

0 comments

Be the first to share your thoughts.

Like this prediction?

Join to make your opinion count.